Epiretinal Membrane Clinical Trial
— MQUESTOfficial title:
Measuring Subjective Quality of Vision and Metamorphopsia Before and After Epiretinal Membrane and Macular Hole Surgery
Verified date | December 2021 |
Source | University Hospital of Wales |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Assessing metamorphopsia and quality of vision pre and post epiretinal and macular hole surgery
Status | Completed |
Enrollment | 50 |
Est. completion date | October 31, 2021 |
Est. primary completion date | October 31, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Participant is willing and able to give informed consent - >18 years old - Patients listed for epi retinal and macular hole surgery - Patient is able to perform study procedures Exclusion Criteria: - Patients who are diagnosed with a condition other than epiretinal membrane or macular hole - Patients not undergoing epiretinal or macular hole surgery - Patients will be excluded if there are any complications within surgery, or undergo any procedures that is not an epiretinal or macular hole surgery (i.e vitrectomy, phacoemulsification (lens extraction) as this can affect visual outcomes. |
Country | Name | City | State |
---|---|---|---|
United Kingdom | University Hospital of Wales | Cardiff |
Lead Sponsor | Collaborator |
---|---|
Hayley Westwood |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Assess correlations between the Mcallinden and Metamorphopsia questionnaire scores and objective clinical parameters | do the questionnaires show changes pre and post surgery and do they match clinical outcomes | Pre surgery and 2-3 month post surgery | |
Primary | Compare the responses of the McAllinden and Metamorphopsia Questionnaire | analysing changes to responses in the 2 questionnaires pre and post surgery | pre surgery and 2 - 3 months post surgery | |
Secondary | Changes to BCVA score | Patients BCVA pre and post surgery to see if there is an improvement | Pre surgery and 2-3 months post surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03332758 -
Inflammasomes in Cell Death in FTMH, ERM, and RRD
|
||
Active, not recruiting |
NCT04130841 -
Effects of Internal Limiting Membrane Peeling on Visual Function in Epiretinal Membrane Surgery
|
N/A | |
Recruiting |
NCT03713268 -
Intraoperative OCT Guidance of Intraocular Surgery II
|
||
Terminated |
NCT01532765 -
Randomized Trial Comparing Epiretinal Membrane Surgery With and Without Internal Limiting Membrane Removal
|
N/A | |
Completed |
NCT01474655 -
Retinal Layers and Visual Rehabilitation After Epiretinal Membrane Removal
|
N/A | |
Active, not recruiting |
NCT04120311 -
Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole
|
Phase 1 | |
Completed |
NCT04445142 -
Fovea ERM After Fovea-sparing ILM Peeling
|
||
Recruiting |
NCT01701518 -
A Pilot Study of the Effectiveness of Intra-operative Ozurdex® in Vitrectomy Surgery for Epiretinal Membranes
|
N/A | |
Completed |
NCT01627977 -
Association of Lutein, Zeaxanthin and Brilliant Blue in Chromovitrectomy
|
Phase 3 | |
Completed |
NCT01771939 -
Phacoemulsification and 25 Gauge (25G) Vitrectomy Versus Phacoemulsification Only in Idiopathic Epiretinal Membranes
|
N/A | |
Completed |
NCT00408720 -
Comparison of a Spectral OCT/SLO With the Stratus OCT for Imaging Various Retinal Pathologies
|
N/A | |
Active, not recruiting |
NCT04306718 -
Cultivation of Hyalocytes From ILM and ERM Samples: a Pilot Study
|
N/A | |
Recruiting |
NCT01985490 -
Change in Foveal Avascular Zone After Removal of Epiretinal Membrane and Internal Limiting Membrane
|
N/A | |
Completed |
NCT01238393 -
Treatment of Epiretinal Membranes With Ranibizumab
|
N/A | |
Terminated |
NCT00333060 -
Study of OT-551 Eye Drops to Prevent or Delay Progression of Nuclear Cataracts Following Vitreous Removal
|
Phase 2 | |
Completed |
NCT05287269 -
Ocular Coherence Tomography During Cataract Assessment
|
||
Recruiting |
NCT05138315 -
Quantification of Metamorphopsia in Patients With Epiretinal Membranes
|
N/A | |
Recruiting |
NCT03661593 -
Aniseikonia in Epiretinal Membrane Patients
|
N/A | |
Completed |
NCT03457584 -
Effect of Air-tamponade on Intraretinal Cystoid Changes After Membrane Peeling
|
N/A | |
Terminated |
NCT04802265 -
EpiRetinal Membrane Peeling and Internal Limiting Membrane
|